Zoloft, Paxil, Luvox And Prozac:: All New Information To Help You Choose The Right Antidepressant (Mass Market Paperback)

by Donald L. Sullivan (Author)

Editorial Reviews

Product Description

Zoloft, Paxil, Luvox and Prozac are currently used by more than five million Americans. If you suffer from depression, obsessive-compulsive disorder, anxiety, or an eating disorder, these drugs, known as Selective Serotonin Reuptake Inhibitors (SSRIs), may bring relief. First prescribed as antidepressants, the SSRIs are now used to treat a wide range of ailments, including anxiety, pain, obesity, migraines, and stroke. But the drugs are not identical--and how do you determine which is right for you? In Zoloft, Paxil, Luvox and Prozac you'll learn the differences between the drugs and how to work with your physician to identify the best SSRI for you.

This easy-to-use guide answers all your questions--

Which of these drugs is most effective in treating depression?

How do I know if I'm depressed,l or just "feeling blue?"

What kind of disorders, other than depression, respond to these medications?

How does my doctor determine which of these drugs to prescribe?

How do these drugs interact with other medications?

How long does it take for an antidepressant to take effect?

What are the symptoms of depression in children?

Can children take SSRIs?

And Much More!

Product Details

• Mass Market Paperback: 224 pages
• Publisher: Avon (April 6, 1999)
• Language: English
• ISBN-10: 0380795183
• ISBN-13: 978-0380795185
• Product Dimensions: 6.8 x 4.2 x 0.8 inches
• Shipping Weight: 4 ounces
• Average Customer Review: 1.5 out of 5 stars See all reviews (4 customer reviews)
• Amazon.com Sales Rank: #2,462,661 in Books (See Bestsellers in Books)

Customer Reviews

Most Helpful Customer Reviews

36 of 37 people found the following review helpful:

1.0 out of 5 stars There is little new information in this book., April 19, 1999

By A Customer

Despite its claim to offer the latest news regarding antidepressants, this book basically is compilation of already published information. It barely mentions the newer classes of drugs (post SSRIs: Remeron, Effexor, Wellbutrin, Serzone) and doesn't even mention the most popular SSRI in the world, Celexa. As far as I could tell, the author, a pharmacist and not a doctor, got all of his anecdotal evidence from one actual physician--the one who wrote the brief introduction. There is nothing in this book that one couldn't easily find surfing the Internet (particularly at these drugs' own Web sites) in about half an hour.

27 of 29 people found the following review helpful:

3.0 out of 5 stars There's not much NEW INFORMATION here., April 12, 1999

By A Customer

This book, published in April 1999, claims to offer "new information" on the new antidepressants. If you have not done any research whatsoever on these drugs you may find this to be true. However over 1/2 of this book is dedicated to a review of each of the 4 antidepresants in the title. The information is almost straight out of the technical documents already published by the manufactures of the drugs. Additionally the author is a pharmicist and NOT an M.D. I do not mean to knock the pharmacy profession but I would feel more comfortable getting this kind of information from a qualified M.D. I must admit that I had done research on these drugs on my own prior to reading this text. If you are considering using these drugs and have not done any research you will find a lot of useful information here.

0 of 1 people found the following review helpful:

1.0 out of 5 stars Help WHO choose?, October 5, 2005

By	De Lyn Wolcott (Lubbock, TX, USA) - See all my reviews (REAL NAME)

These medications should not be "chosen" by the patient. Considering the side effects and withdrawal symptoms associated with all of these medications, they should not be "chosen" at all. This book is very misleading and could be very dangerous to the general public. These medications do have their place in society, but only at the discretion of a fully-informed psychiatrist along with his full testing and evaluation of the patient.